FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2005411978> ?p ?o ?g. }

• W2005411978 endingPage "982" @default.
• W2005411978 startingPage "975" @default.
• W2005411978 abstract "The extreme radiosensitivity of indolent lymphomas was reported in the early years of radiotherapy (RT). The efficacy of low-dose total body irradiation (1.5–2 Gy) was particularly demonstrative. Higher doses were considered appropriate for localized disease. The optimal (or conventional) dose of curative RT derived from the early studies was determined to be 30–35 Gy. Nevertheless, in older series addressing the tumoricidal radiation dose in non-Hodgkin's lymphomas, investigators noted that a significant number of “nodular” lymphomas were controlled with a dose of <22 Gy for >3 years. The idea of reintroducing localized low-dose radiotherapy (LDRT) for indolent non-Hodgkin's lymphomas came from a clinical observation. The first study showing the high efficacy of LDRT (4 Gy in two fractions of 2 Gy within 3 days) in selected patients with chemoresistant, indolent, non-Hodgkin's lymphomas was published in 1994. Since this first report, at least eight series of patients treated with localized LDRT have been published, showing a 55% complete response rate in irradiated sites, with a median duration of 15–42 months. How LDRT induces lymphoma cell death remains partly unknown. However, some important advances have recently been reported. Localized LDRT induces an apoptosis of follicular lymphoma cells. This apoptotic cell death elicits an immune response mediated by macrophages and dendritic cells. Follicular lymphoma is probably an ideal model to explore these mechanisms. This review also discusses the future of LDRT for follicular lymphoma. The extreme radiosensitivity of indolent lymphomas was reported in the early years of radiotherapy (RT). The efficacy of low-dose total body irradiation (1.5–2 Gy) was particularly demonstrative. Higher doses were considered appropriate for localized disease. The optimal (or conventional) dose of curative RT derived from the early studies was determined to be 30–35 Gy. Nevertheless, in older series addressing the tumoricidal radiation dose in non-Hodgkin's lymphomas, investigators noted that a significant number of “nodular” lymphomas were controlled with a dose of <22 Gy for >3 years. The idea of reintroducing localized low-dose radiotherapy (LDRT) for indolent non-Hodgkin's lymphomas came from a clinical observation. The first study showing the high efficacy of LDRT (4 Gy in two fractions of 2 Gy within 3 days) in selected patients with chemoresistant, indolent, non-Hodgkin's lymphomas was published in 1994. Since this first report, at least eight series of patients treated with localized LDRT have been published, showing a 55% complete response rate in irradiated sites, with a median duration of 15–42 months. How LDRT induces lymphoma cell death remains partly unknown. However, some important advances have recently been reported. Localized LDRT induces an apoptosis of follicular lymphoma cells. This apoptotic cell death elicits an immune response mediated by macrophages and dendritic cells. Follicular lymphoma is probably an ideal model to explore these mechanisms. This review also discusses the future of LDRT for follicular lymphoma." @default.
• W2005411978 created "2016-06-24" @default.
• W2005411978 creator A5014973359 @default.
• W2005411978 creator A5030811791 @default.
• W2005411978 creator A5031977714 @default.
• W2005411978 creator A5038128263 @default.
• W2005411978 creator A5056781493 @default.
• W2005411978 creator A5073216761 @default.
• W2005411978 date "2010-11-01" @default.
• W2005411978 modified "2023-09-30" @default.
• W2005411978 title "Localized Low-Dose Radiotherapy for Follicular Lymphoma: History, Clinical Results, Mechanisms of Action, and Future Outlooks" @default.
• W2005411978 cites W1033071595 @default.
• W2005411978 cites W1485476587 @default.
• W2005411978 cites W169577875 @default.
• W2005411978 cites W1819590342 @default.
• W2005411978 cites W1874821077 @default.
• W2005411978 cites W1965867669 @default.
• W2005411978 cites W1969751970 @default.
• W2005411978 cites W1976480307 @default.
• W2005411978 cites W1978972542 @default.
• W2005411978 cites W1979574823 @default.
• W2005411978 cites W1996255804 @default.
• W2005411978 cites W1999020268 @default.
• W2005411978 cites W1999591023 @default.
• W2005411978 cites W2003054228 @default.
• W2005411978 cites W2005822214 @default.
• W2005411978 cites W2006992549 @default.
• W2005411978 cites W2008402216 @default.
• W2005411978 cites W2010105078 @default.
• W2005411978 cites W2011169439 @default.
• W2005411978 cites W2013456322 @default.
• W2005411978 cites W2017029669 @default.
• W2005411978 cites W2018874850 @default.
• W2005411978 cites W2022013393 @default.
• W2005411978 cites W2025421597 @default.
• W2005411978 cites W2034401200 @default.
• W2005411978 cites W2036112796 @default.
• W2005411978 cites W2042528850 @default.
• W2005411978 cites W2043946207 @default.
• W2005411978 cites W2047902191 @default.
• W2005411978 cites W2048311499 @default.
• W2005411978 cites W2048488232 @default.
• W2005411978 cites W2051455084 @default.
• W2005411978 cites W2053466797 @default.
• W2005411978 cites W2058800025 @default.
• W2005411978 cites W2059682256 @default.
• W2005411978 cites W2067488977 @default.
• W2005411978 cites W2077007959 @default.
• W2005411978 cites W2087565022 @default.
• W2005411978 cites W2090750060 @default.
• W2005411978 cites W2093424661 @default.
• W2005411978 cites W2093629917 @default.
• W2005411978 cites W2093994320 @default.
• W2005411978 cites W2094708089 @default.
• W2005411978 cites W2112965316 @default.
• W2005411978 cites W2120096435 @default.
• W2005411978 cites W2120886258 @default.
• W2005411978 cites W2127733313 @default.
• W2005411978 cites W2132598458 @default.
• W2005411978 cites W2133739473 @default.
• W2005411978 cites W2136851956 @default.
• W2005411978 cites W2141509776 @default.
• W2005411978 cites W2144677479 @default.
• W2005411978 cites W2146595682 @default.
• W2005411978 cites W2147119208 @default.
• W2005411978 cites W2152128451 @default.
• W2005411978 cites W2153007514 @default.
• W2005411978 cites W2155775348 @default.
• W2005411978 cites W2157924483 @default.
• W2005411978 cites W2160575379 @default.
• W2005411978 cites W2165207421 @default.
• W2005411978 cites W2167635913 @default.
• W2005411978 cites W2203017689 @default.
• W2005411978 cites W2590211551 @default.
• W2005411978 doi "https://doi.org/10.1016/j.ijrobp.2010.06.056" @default.
• W2005411978 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20970029" @default.
• W2005411978 hasPublicationYear "2010" @default.
• W2005411978 type Work @default.
• W2005411978 sameAs 2005411978 @default.
• W2005411978 citedByCount "44" @default.
• W2005411978 countsByYear W20054119782012 @default.
• W2005411978 countsByYear W20054119782013 @default.
• W2005411978 countsByYear W20054119782014 @default.
• W2005411978 countsByYear W20054119782015 @default.
• W2005411978 countsByYear W20054119782016 @default.
• W2005411978 countsByYear W20054119782017 @default.
• W2005411978 countsByYear W20054119782018 @default.
• W2005411978 countsByYear W20054119782019 @default.
• W2005411978 countsByYear W20054119782020 @default.
• W2005411978 countsByYear W20054119782021 @default.
• W2005411978 countsByYear W20054119782022 @default.
• W2005411978 countsByYear W20054119782023 @default.
• W2005411978 crossrefType "journal-article" @default.
• W2005411978 hasAuthorship W2005411978A5014973359 @default.
• W2005411978 hasAuthorship W2005411978A5030811791 @default.
• W2005411978 hasAuthorship W2005411978A5031977714 @default.
• W2005411978 hasAuthorship W2005411978A5038128263 @default.
• W2005411978 hasAuthorship W2005411978A5056781493 @default.

• next